Asia-Pacific Electrophysiology Mapping and Ablation Devices Market – Industry Trends and Forecast to 2030

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market, By Type (Ablation Devices and Electrophysiology Mapping), Indication (Cardiology, Cancer, Cosmetic Surgery, Gynecology, Oncology, Ophthalmology, Orthopedic Treatment, Pain Management, Urology, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia (AVNRT), Atrial Fibrillation, Wolff-Parkinson-White Syndrome (WPW) and Others), Function (Conventional. Advanced, Cryoablation, Microwave and Ultrasound), Procedure (Aesthetics-Skin Rejuvenation and Tightening, Aesthetics-Body Sculpting, Fat Reduction, and The Minimization In The Appearance Of Cellulite, Benign Prostatic Hyperplasia, Transurethral Needle Ablation, Laser And Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation of The Prostate, Stress Urinary Incontinence, Menorrhagia/Endometrial Ablation, Uterine Fibroids, Spinal Decompression And Denervation, Varicose Veins, Atrial Fibrillation, Tumor Ablation and Others), End-User (Hospitals, Ambulatory Surgery Center, Diagnostic Center, Cardiac Catheterization Laboratories, Specialty Clinics and Others) – Industry Trends and Forecast to 2030.

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Analysis and Size

Nearly 5 million people worldwide were affected with AF in 2018, according to ELSO data. Of them, 2 million had the disease identified while 1 million went misdiagnosed, resulting in an estimated mortality rate of 3% and 6%, respectively. Electrophysiology mapping and ablation devices are used for the treatment of various arrhythmia conditions such as atrial fibrillation, premature ventricular contractions (PVC), atrial flutter, AV nodal re-entry tachycardia and among others. With a market share of 29.0% in terms of sales in 2017, the PVC sector dominated the industry. One of the key elements in its domination over other application categories that year was the high prevalence of PVCs among patients with hypertension.

Data Bridge Market Research analyses that the electrophysiology mapping and ablation devices market which is USD 2180.360 million in 2022, is expected to reach USD 4917.10 million by 2030, at a CAGR of 10.7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Scope and Segmentation      

Market Definition

The technique of electrophysiology mapping is used to identify the electrical impulses of the heart. The equipment used for mapping electrophysiology, which computes or maps the electrical activity of the heart. Furthermore, these tools are frequently utilised to treat patients with cardiac rhythm issues such arrhythmias and many other heart-related illnesses. Ablation devices are frequently used to treat the defective heart tissue that can result in arrhythmias like atrial flutter and atrial fibrillation as well as other chronic diseases like lung, liver, prostate, and kidney cancer. In order to treat patients, ablation devices generate heat using energy, laser, microwave, and radiofrequency.

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Dynamics

Drivers

• Increasing incidence of cardiac arrhythmias

The global prevalence of cardiac arrhythmias is high, with an estimated 2-3% of the general population suffering from them. This figure is expected to rise in the future due to a variety of factors including an ageing population, rising obesity and diabetes rates, and increased exposure to environmental stressors. This will result in a large number of patients requiring electrophysiology mapping and ablation devices for treatment.

Opportunities

• Growing demand for minimally invasive procedures

Minimally invasive procedures are in high demand across all medical specialties due to their numerous advantages over traditional surgery, such as reduced pain, shorter hospital stay, faster recovery time, and among others. Electrophysiology mapping and ablation devices are ideal for use in minimally invasive procedures because of their small size and portability. This will help them expand in the coming years.

Restraints/Challenges

• High cost

In developing and underdeveloped economies, improper and unfavourable reimbursement scenarios will hamper the market growth. Furthermore, the high costs associated with electrophysiology products will present additional challenges to the market. Stringent regulatory standards will also slow market growth. The price of an EP recording system is USD 160,000. EP procedures are generally expensive due to high capital, training, and maintenance costs. A catheter ablation procedure, for example, typically costs between USD 4,000 and $6,500.

This electrophysiology mapping and ablation devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the electrophysiology mapping and ablation devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2020, Siemens Healthineers AG introduced the ACUSON Redwood Ultrasound System in India. This cutting-edge device has numerous uses in cardiology mapping and identifies and diagnoses lesions. by expanding its line of products and stimulating the market for electrophysiology mapping and ablation devices in the Asia-Pacific region.
• In 2019, Medtronic acquired EPIX Therapeutics, Inc. to expand its product portfolio. EPIX Therapeutics, Inc is developing catheter-based, temperature-controlled cardiac ablation devices to treat patients with cardiac arrhythmias such as atrial fibrillation.

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Scope

The electrophysiology mapping and ablation devices market is segmented on the basis of type, indication, function, procedure and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Ablation Devices
• Electrophysiology Mapping

Indication

• Cardiology
• Cancer
• Cosmetic Surgery
• Gynecology
• Oncology
• Ophthalmology
• Orthopedic Treatment
• Pain Management
• Urology
• Atrial Flutter
• Atrioventricular Nodal Reentry Tachycardia (AVNRT)
• Atrial Fibrillation
• Wolff-Parkinson-White Syndrome (WPW)
• Others

 Function

• Conventional
• Advanced
• Cryoablation
• Microwave
• Ultrasound

 Procedure

• Aesthetics-Skin Rejuvenation
• Tightening
• Aesthetics-Body Sculpting
• Fat Reduction
• The Minimization in The Appearance of Cellulite
• Benign Prostatic Hyperplasia
• Transurethral Needle Ablation
• Laser
• Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation of The Prostate
• Stress Urinary Incontinence
• Menorrhagia/Endometrial Ablation
• Uterine Fibroids
• Spinal Decompression and Denervation
• Varicose Veins
• Atrial Fibrillation
• Tumor Ablation
• Others

 End-User

• Hospitals
• Ambulatory Surgery Center
• Diagnostic Center
• Cardiac Catheterization Laboratories
• Specialty Clinics
•  Others

Electrophysiology Mapping and Ablation Devices Market Regional Analysis/Insights

The electrophysiology mapping and ablation devices market is analysed and market size insights and trends are provided by country, type, indication, function, procedure and end user as referenced above.

The countries covered in the electrophysiology mapping and ablation devices market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)

In the Asia-Pacific, Japan is dominating the Asia-Pacific electrophysiology mapping and ablation devices market due to increasing research and development in the radiofrequency ablators, and electrophysiology mapping and ablation devices market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The electrophysiology mapping and ablation devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for electrophysiology mapping and ablation devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the electrophysiology mapping and ablation devices market. The data is available for historic period 2011-2021.

Competitive Landscape and Electrophysiology Mapping and Ablation Devices Market Share Analysis

The electrophysiology mapping and ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to electrophysiology mapping and ablation devices market.

Some of the major players operating in the electrophysiology mapping and ablation devices market are:

• Abbott (U.S.)
• Arthrex, Inc. (U.S.)
• TORAY INDUSTRIES, INC. (U.S.)
• Olympus Corporation (Japan)
• Teleflex Incorporated (U.S.)
• MicroPort Scientific Corporation (China)
• BIOTRONIK SE & Co. KG. (Germany)
• Boston Scientific Corporation (U.S.)
• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Japan Lifeline Co., Ltd. (Japan)
• STARmed Co., Ltd. (South Korea)
• Koninklijke Philips N.V. (Netherlands)
• Surgnova (China)
• Medtronic (Ireland)